Possible role of plasma neurotensin on growth hormone regulation in neonates

Objective: To evaluate secretion of plasma neurotensin (NT) which could be involved as a peripheral signal in growth hormone (GH) regulation, NT release was measured during early postnatal life, a period of striking changes in GH secretion. Methods: Blood samples were collected from 19 normal full-term neonates on day 5 and at 3 months of age to evaluate plasma NT concentrations by radioimmunoassay, serum growth hormone (GH) levels using an immunofluorometric assay, and serum insulin-like growth factor-I (IGF-I) values by radioimmunoassay. Results: Five day-old neonates showed significantly higher (p<0.001) mean (±SEM) plasma NT levels (83.55±12.07 fmol/ml) compared with those in 11 prepubertal children and those in 14 adults who were studied as control subjects (13.30±2.90 and 9.70±1.10 fmol/ml, respectively). In 5 day-old neonates we observed significantly higher (p<0.001) serum GH levels (29.53±3.40 ng/ml) compared with those in the prepubertal children (1.26±0.28 ng/ml). Five day-old neonates showed significantly lower (p<0.001) serum IGF-I concentrations (27.01±0.77 ng/ml) than those in the prepubertal children (210±25 ng/ml). At 3 months of age, plasma NT levels (59.37±7.47 fmol/ml) and serum GH values (4.40 ±0.60 ng/ml) were significantly decreased (p< 0.001). At the 3rd month of life, serum IGF-I levels (44.88±4.30 ng/ml) were increased significantly (p<0.001). Conclusions: The human neonate showed very high concentrations of NT and GH in comparison with those observed in control subjects. The postnatal rise in IGF-I values is presumed to determine the fall in serum GH concentrations by stimulating somatostatin secretion. Neurotensin could be involved as a peripheral signal in the inhibitory mechanisms mediated by release of somatostatin.